FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

766045006: acute myeloïde leukemie en myelodysplastisch syndroom, gerelateerd aan alkylerend middel (aandoening)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3660593011 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660594017 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660595016 Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
8142761000146110 acute myeloïde leukemie en myelodysplastisch syndroom, gerelateerd aan alkylerend middel nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
8142771000146116 acute myeloïde leukemie en myelodysplastisch syndroom, gerelateerd aan alkylerend middel (aandoening) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
8469441000146118 AML en myelodysplastisch syndroom, gerelateerd aan alkylerend agens nl Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
3660596015 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660597012 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Causative agent Alkylating agent (substance) true Inferred relationship Some 1
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Associated morphology acute myeloïde leukemie en myelodysplastisch syndroom bij behandeling met alkylerende stof false Inferred relationship Some 1
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Complication of procedure false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a restverschijnsel en/of laat gevolg false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent After Administration of antineoplastic agent true Inferred relationship Some 2
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Due to Administration of antineoplastic agent true Inferred relationship Some 3
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Finding site Bone marrow structure true Inferred relationship Some 1
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a aandoening bij drug of geneesmiddel (aandoening) false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Complication of chemotherapy (disorder) false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Disorder following clinical procedure false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Complication of introduction procedure false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Drug-induced lesion false Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Is a Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent true Inferred relationship Some
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent Associated morphology Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start